SNY – Sanofi

Float Short %

0.21

Margin Of Safety %

Put/Call OI Ratio

1.22

EPS Next Q Diff

0.12

EPS Last/This Y

2.03

EPS This/Next Y

0.51

Price

47.02

Target Price

64.21

Analyst Recom

1.76

Performance Q

-7.48

Relative Volume

1.1

Beta

0.5

Ticker: SNY

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	SNY	49.77	0.59	0.10	53633
2025-08-18	SNY	49.58	0.88	0.93	36957
2025-08-19	SNY	50.17	0.93	15.50	39395
2025-08-20	SNY	50.54	1.20	6.33	45637
2025-08-21	SNY	50.6	1.32	8.82	47084
2025-08-22	SNY	51.35	1.45	0.46	50404
2025-08-25	SNY	50.15	1.44	0.78	50832
2025-08-26	SNY	50.31	1.42	0.82	51151
2025-08-27	SNY	50.11	1.39	2.10	53332
2025-08-28	SNY	49.95	1.38	2.57	53751
2025-08-29	SNY	49.51	1.42	6.38	55309
2025-09-02	SNY	49.58	1.44	0.04	55799
2025-09-03	SNY	49.87	1.30	0.38	58419
2025-09-04	SNY	45.33	1.23	0.58	61102
2025-09-05	SNY	46.48	1.10	0.77	64297
2025-09-08	SNY	46.79	1.18	0.61	63399
2025-09-09	SNY	47.45	1.22	1.62	63496
2025-09-10	SNY	47.17	1.22	0.94	63620
2025-09-11	SNY	47.64	1.21	0.93	64897
2025-09-12	SNY	47.03	1.22	1.86	65357
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	SNY	49.76	3.0	4085.8	4.54
2025-08-18	SNY	49.81	3.0	4035.3	4.54
2025-08-19	SNY	50.19	3.0	3828.4	4.56
2025-08-20	SNY	50.54	3.0	3721.1	4.56
2025-08-21	SNY	50.60	3.0	3657.9	4.56
2025-08-22	SNY	51.35	3.0	3811.1	4.56
2025-08-25	SNY	50.15	3.0	3539.3	4.56
2025-08-26	SNY	50.30	3.0	3980.2	4.56
2025-08-27	SNY	50.11	3.0	3929.8	4.56
2025-08-28	SNY	49.94	3.0	3934.7	4.56
2025-08-29	SNY	49.47	3.0	3860.3	4.56
2025-09-02	SNY	49.60	3.0	4064.6	4.56
2025-09-03	SNY	49.90	3.0	4719.3	4.56
2025-09-04	SNY	45.33	3.0	3432.8	4.56
2025-09-05	SNY	46.50	3.9	3194.5	4.57
2025-09-08	SNY	46.80	4.7	4579.2	4.58
2025-09-09	SNY	47.44	4.7	4815.1	4.58
2025-09-10	SNY	47.17	4.7	4473.4	4.62
2025-09-11	SNY	47.65	4.7	4683.8	4.62
2025-09-12	SNY	47.02	4.7	4377.9	4.62
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	SNY	0	-1.77	0.13
2025-08-18	SNY	0	-1.70	0.13
2025-08-19	SNY	0	-1.70	0.13
2025-08-20	SNY	0	-1.70	0.13
2025-08-21	SNY	0	-1.70	0.13
2025-08-22	SNY	0	-1.70	0.13
2025-08-25	SNY	0	-0.57	0.13
2025-08-26	SNY	0	-0.57	0.13
2025-08-27	SNY	0	-0.57	0.18
2025-08-28	SNY	0	-0.57	0.18
2025-08-29	SNY	0	-0.57	0.18
2025-09-02	SNY	0	-0.68	0.18
2025-09-03	SNY	0	-0.68	0.18
2025-09-04	SNY	0	-0.68	0.18
2025-09-05	SNY	0	-0.68	0.18
2025-09-08	SNY	0	-0.33	0.18
2025-09-09	SNY	0	-0.33	0.18
2025-09-10	SNY	0	-0.33	0.18
2025-09-11	SNY	0	-0.33	0.21
2025-09-12	SNY	0	-0.33	0.21
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.9

Avg. EPS Est. Current Quarter

1.62

Avg. EPS Est. Next Quarter

1.02

Insider Transactions

Institutional Transactions

-0.33

Beta

0.5

Average Sales Estimate Current Quarter

12614

Average Sales Estimate Next Quarter

11284

Fair Value

62.16

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

21.8

Max Drawdown 5-Year %

-33.5

Target Price

64.21

P/E

11.74

Forward P/E

9.43

PEG

0.91

P/S

2.65

P/B

1.39

P/Free Cash Flow

10.61

EPS

4.01

Average EPS Est. Cur. Y

4.62

EPS Next Y. (Est.)

5.12

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

22.98

Relative Volume

1.1

Return on Equity vs Sector %

-18.5

Return on Equity vs Industry %

-27.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.06

EBIT Estimation

4377.9

Sanofi

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 82878

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Innate Pharma SA for a natural killer cell engager program targeting B7-H3; and Blackstone Life Sciences to develop pivotal studies and clinical development program. Further, it has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop novel targeted protein degradation therapies; Denali Therapeutics Inc. to treat a range of systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for the discovery and development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab, as well as a strategic alliance with the Department of Health Abu Dhabi for the development of global vaccines. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

stock quote shares SNY – Sanofi Stock Price stock today

news today SNY – Sanofi stock forecast ,stock prediction 2023 2024 2025

marketwatch SNY – Sanofi yahoo finance google finance

stock history SNY – Sanofi invest stock market

stock prices SNY premarket after hours

ticker SNY fair value insiders trading

TTE – Total Energies SE

Float Short %

0.21

Margin Of Safety %

-10

Put/Call OI Ratio

1.02

EPS Next Q Diff

0.1

EPS Last/This Y

0.15

EPS This/Next Y

0.55

Price

61.15

Target Price

72.72

Analyst Recom

1.69

Performance Q

-3.06

Relative Volume

1.34

Beta

0.55

Ticker: TTE

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	TTE	62.26	0.68	0.02	73444
2025-08-18	TTE	61.55	1.04	0.18	45971
2025-08-19	TTE	62.32	0.91	0.12	50842
2025-08-20	TTE	63.09	0.88	0.71	51620
2025-08-21	TTE	63.46	0.90	0.03	53163
2025-08-22	TTE	64.04	0.88	0.82	53646
2025-08-25	TTE	63.24	0.88	1.43	56304
2025-08-26	TTE	61.95	0.94	3.19	60241
2025-08-27	TTE	62.07	0.99	0.25	63644
2025-08-28	TTE	62.11	0.98	0.10	64180
2025-08-29	TTE	62.77	0.96	1.72	64791
2025-09-02	TTE	62.58	0.98	1.57	67329
2025-09-03	TTE	61.7	0.98	0.76	67540
2025-09-04	TTE	61.53	0.99	1.13	67638
2025-09-05	TTE	61	0.96	7.41	67447
2025-09-08	TTE	61.09	0.99	0.51	68710
2025-09-09	TTE	61.55	0.99	0.52	68847
2025-09-10	TTE	62.19	0.99	15.11	69441
2025-09-11	TTE	61.41	1.02	0.40	70499
2025-09-12	TTE	61.15	1.02	0.28	70503
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	TTE	62.25	-2.5	-676.2	6.96
2025-08-18	TTE	61.56	-2.5	-1176.2	6.96
2025-08-19	TTE	62.32	-0.9	-1077.9	6.89
2025-08-20	TTE	63.09	-0.9	-1102.8	6.89
2025-08-21	TTE	63.46	-0.9	-1112.3	6.89
2025-08-22	TTE	64.04	-0.9	-1132.6	6.89
2025-08-25	TTE	62.75	-0.9	-1655.5	6.89
2025-08-26	TTE	61.92	-0.9	-1224.5	6.89
2025-08-27	TTE	62.06	-0.9	-792.5	6.89
2025-08-28	TTE	62.11	-0.9	-831.8	6.89
2025-08-29	TTE	62.78	-0.9	-629.6	6.89
2025-09-02	TTE	62.58	-0.9	-1230.9	6.89
2025-09-03	TTE	61.70	-0.9	-2664.3	6.89
2025-09-04	TTE	61.56	-0.9	-2447.1	6.89
2025-09-05	TTE	60.95	-0.9	-2655.5	6.89
2025-09-08	TTE	61.10	-0.9	-2294.8	6.89
2025-09-09	TTE	61.56	-0.9	-2171.9	6.89
2025-09-10	TTE	62.21	-0.9	-2458.4	6.89
2025-09-11	TTE	61.40	-0.9	-2732.3	6.89
2025-09-12	TTE	61.15	-0.9	-2573.8	6.89
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	TTE	0	-1.94	0.20
2025-08-18	TTE	0	-1.48	0.20
2025-08-19	TTE	0	-1.48	0.20
2025-08-20	TTE	0	-1.48	0.20
2025-08-21	TTE	0	-1.48	0.20
2025-08-22	TTE	0	-1.48	0.20
2025-08-25	TTE	0	0.50	0.20
2025-08-26	TTE	0	0.50	0.20
2025-08-27	TTE	0	0.50	0.20
2025-08-28	TTE	0	0.50	0.20
2025-08-29	TTE	0	0.50	0.20
2025-09-02	TTE	0	0.48	0.20
2025-09-03	TTE	0	0.48	0.20
2025-09-04	TTE	0	0.48	0.20
2025-09-05	TTE	0	0.48	0.20
2025-09-08	TTE	0	0.25	0.20
2025-09-09	TTE	0	0.25	0.20
2025-09-10	TTE	0	0.25	0.20
2025-09-11	TTE	0	0.25	0.21
2025-09-12	TTE	0	0.25	0.21
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

1.57

Avg. EPS Est. Current Quarter

1.73

Avg. EPS Est. Next Quarter

1.67

Insider Transactions

Institutional Transactions

0.25

Beta

0.55

Average Sales Estimate Current Quarter

43884

Average Sales Estimate Next Quarter

33650

Fair Value

54.78

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

18.4

Max Drawdown 5-Year %

-26.2

Target Price

72.72

P/E

10.92

Forward P/E

8.38

PEG

6.66

P/S

0.72

P/B

1.15

P/Free Cash Flow

11.8

EPS

5.6

Average EPS Est. Cur. Y

6.89

EPS Next Y. (Est.)

7.45

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

6.83

Relative Volume

1.34

Return on Equity vs Sector %

0.1

Return on Equity vs Industry %

0.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.09

EBIT Estimation

-2573.8

TotalEnergies SE

Sector: Energy

Industry: Oil & Gas Integrated

Employees: 62796

TotalEnergies SE, a multi-energy company, produces and markets oil and biofuels, natural gas, biogas and low-carbon hydrogen, renewables, and electricity in France, rest of Europe, and internationally. It operates through five segments: Exploration & Production, Integrated LNG, Integrated Power, Refining & Chemicals, and Marketing & Services. The Exploration & Production segment is involved in the exploration and production of oil and natural gas. The Integrated LNG segment comprises the integrated gas chain, including upstream and midstream liquified natural gas (LNG) activities, as well as biogas, hydrogen, and gas trading activities. The Integrated Power segment includes generation, storage, electricity trading, and B2B-B2C distribution of gas and electricity. The Refining & Chemicals segment consists of refining, petrochemicals, and specialty chemicals, as well as oil supply, trading, and marine shipping activities. The Marketing & Services segment supplies and markets petroleum products. The company was formerly known as TOTAL SE and changed its name to TotalEnergies SE in June 2021. TotalEnergies SE was founded in 1924 and is headquartered in Courbevoie, France.

stock quote shares TTE – Total Energies SE Stock Price stock today

news today TTE – Total Energies SE stock forecast ,stock prediction 2023 2024 2025

marketwatch TTE – Total Energies SE yahoo finance google finance

stock history TTE – Total Energies SE invest stock market

stock prices TTE premarket after hours

ticker TTE fair value insiders trading

CSTM – Constellium SE

Float Short %

2.94

Margin Of Safety %

Put/Call OI Ratio

0.29

EPS Next Q Diff

0.15

EPS Last/This Y

0.65

EPS This/Next Y

0.54

Price

14.93

Target Price

18.33

Analyst Recom

Performance Q

7.02

Relative Volume

0.56

Beta

1.72

Ticker: CSTM

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	CSTM	14.43	0.29	0.00	31482
2025-08-18	CSTM	14.13	0.28	1.13	20133
2025-08-19	CSTM	14.62	0.28	0.10	20171
2025-08-20	CSTM	14.41	0.28	7.00	20203
2025-08-21	CSTM	14.23	0.29	2.23	20259
2025-08-22	CSTM	14.74	0.29	0.11	20331
2025-08-25	CSTM	14.3	0.29	0.25	20348
2025-08-26	CSTM	14.55	0.29	1.00	20353
2025-08-27	CSTM	14.61	0.29	1.10	20355
2025-08-28	CSTM	14.53	0.29	999.99	20365
2025-08-29	CSTM	14.5	0.29	0.04	20366
2025-09-02	CSTM	13.93	0.29	0.20	20414
2025-09-03	CSTM	13.81	0.29	0.00	20480
2025-09-04	CSTM	13.95	0.29	0.03	20477
2025-09-05	CSTM	14.59	0.29	3.50	20502
2025-09-08	CSTM	14.33	0.29	0.12	20506
2025-09-09	CSTM	13.72	0.29	0.00	20532
2025-09-10	CSTM	14.5	0.29	0.00	20536
2025-09-11	CSTM	14.98	0.29	0.00	20356
2025-09-12	CSTM	14.94	0.29	0.00	20354
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	CSTM	14.43	1109.1	-	1.03
2025-08-18	CSTM	14.14	1109.1	-	1.03
2025-08-19	CSTM	14.62	1109.1	-	1.03
2025-08-20	CSTM	14.40	1109.1	-	1.03
2025-08-21	CSTM	14.24	1109.1	-	1.03
2025-08-22	CSTM	14.74	1109.1	-	1.03
2025-08-25	CSTM	14.29	1109.1	-	1.03
2025-08-26	CSTM	14.56	1109.1	-	1.03
2025-08-27	CSTM	14.60	1109.1	-	1.03
2025-08-28	CSTM	14.53	1109.1	-	1.03
2025-08-29	CSTM	14.49	1109.1	-	1.03
2025-09-02	CSTM	13.93	1109.1	-	1.03
2025-09-03	CSTM	13.82	1109.1	-	1.03
2025-09-04	CSTM	13.94	1109.1	-	1.03
2025-09-05	CSTM	14.59	1109.1	-	1.03
2025-09-08	CSTM	14.33	1109.1	-	1.03
2025-09-09	CSTM	13.73	1109.1	-	1.03
2025-09-10	CSTM	14.50	1109.1	-	1.03
2025-09-11	CSTM	14.98	1109.1	-	1.03
2025-09-12	CSTM	14.93	1109.1	-	1.03
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	CSTM	0.00	-3.69	3.03
2025-08-18	CSTM	0.00	-7.40	3.03
2025-08-19	CSTM	0.00	-7.40	3.03
2025-08-20	CSTM	0.00	-7.40	3.03
2025-08-21	CSTM	0.00	-7.40	3.03
2025-08-22	CSTM	0.00	-7.40	3.03
2025-08-25	CSTM	0.00	0.87	3.03
2025-08-26	CSTM	0.00	0.87	3.03
2025-08-27	CSTM	0.00	0.87	2.86
2025-08-28	CSTM	0.00	0.87	2.86
2025-08-29	CSTM	0.00	0.87	2.86
2025-09-02	CSTM	0.00	1.01	2.86
2025-09-03	CSTM	0.00	1.01	2.86
2025-09-04	CSTM	0.00	1.01	2.86
2025-09-05	CSTM	0.00	1.01	2.86
2025-09-08	CSTM	0.00	-0.07	2.86
2025-09-09	CSTM	0.00	-0.07	2.86
2025-09-10	CSTM	0.00	-0.07	2.86
2025-09-11	CSTM	0.00	-0.07	2.94
2025-09-12	CSTM	0.00	-0.07	2.94
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.09

Avg. EPS Est. Current Quarter

0.35

Avg. EPS Est. Next Quarter

0.24

Insider Transactions

Institutional Transactions

-0.07

Beta

1.72

Average Sales Estimate Current Quarter

1810

Average Sales Estimate Next Quarter

1693

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

35.7

Max Drawdown 5-Year %

-66.3

Target Price

18.33

P/E

77.69

Forward P/E

8.52

PEG

1.09

P/S

0.27

P/B

2.67

P/Free Cash Flow

EPS

0.19

Average EPS Est. Cur. Y

1.03

EPS Next Y. (Est.)

1.57

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

0.36

Relative Volume

0.56

Return on Equity vs Sector %

-10.7

Return on Equity vs Industry %

-12.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Constellium SE

Sector: Basic Materials

Industry: Aluminum

Employees: 12000

Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the aerospace, packaging, automotive, commercial transportation, general industrial, and defense end-markets. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry. The Packaging & Automotive Rolled Products segment produces and develops rolled aluminum products, including canstock and closure stock for the beverage and food industry, as well as foil stock for the flexible packaging market. This segment also supplies automotive body sheets, heat exchangers, and battery foil products for the automotive market. The Aerospace & Transportation segment provides aluminum products including plate, sheet, and extrusions to aerospace, space, commercial transportation, general industrial, and defense sectors. The Automotive Structures & Industry segment offers structural solutions for the automotive industry including crash management systems, body structures, side impact beams, and battery enclosure components; soft and hard alloy extrusions for automotive, transportation, and general industrial applications; and profiles for rail and general industrial applications. This segment also provides downstream technology and services, which include pre-machining, surface treatment, research and development, and technical support services. It sells its products directly or through distributors in France, Germany, the Czech Republic, the United Kingdom, Switzerland, and the United States, as well as South Korea and China. The company was incorporated in 2010 and is headquartered in Paris, France.

stock quote shares CSTM – Constellium SE Stock Price stock today

news today CSTM – Constellium SE stock forecast ,stock prediction 2023 2024 2025

marketwatch CSTM – Constellium SE yahoo finance google finance

stock history CSTM – Constellium SE invest stock market

stock prices CSTM premarket after hours

ticker CSTM fair value insiders trading

SNY – Sanofi

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: SNY

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

TTE – Total Energies SE

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: TTE

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y